AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.9 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Mitigating the effects of Endothelin-1 following a minimally invasive surgery reduces the blood-brain barrier permeability in a rabbit model of intracerebral hemorrhage

Chen LiaXianlin MengaLikun Wanga( )Siying RenaNatahnael MateibGuofeng Wua
Emergency Department, The Affiliated Hospital of Guizhou Medical University, Guiyang City, Guizhou, China
Department of Ophthalmology, University of Southern California, Los Angeles, CA, United States
Show Author Information

Abstract

Objective

The aim of the current study is to evaluate if ETB inhibition following ICH can mitigate the deleterious impact of ET-1, e.g., BBB disruption, and improve neurological function.

Methods

A total of 90 male rabbits (2.8–3.4 kg) were randomly assigned to the following groups (n = 10 per group): normal control (NC), pseudo-control (PC), drug control using normal saline (DC), model control (MC + ICH), minimally invasive surgery (MIS + ICH), minimally invasive surgery + ET-1 receptor agonist (MIS + IRL1620 + ICH), IRL1620 + ICH, ET-1 receptor antagonist (BQ788 + ICH), and IS + BQ788 + ICH. ICH was induced in all groups except for NC, DC and PC groups.

Results

The purdy score, ET-1, MDA, MMP-9, BWC, and BBB permeability were decreased in groups treated with BQ788 and increased in groups treated with IRL1620. The combination of MIS + BQ788 markedly decreased these deleterious outcomes (purdy score, ET-1, MDA, MMP-9, BWC, and BBB permeability) compared to the MIS group.

Conclusions

Using a non-selective antagonist of ETB, deleterious outcomes associated with increased levels of ET-1 following ICH were ameliorated.

References

1

Krishnamurthi RV, Ikeda T, Feigin VL. Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017. Neuroepidemiology. 2020;54(2):171–179.

2

Urday S et al.. Targeting secondary injury in intracerebral haemorrhage–perihaematomal oedema. Nat Rev Neurol. 2015;11(2):111–122.

3

Ramanan M, Shankar A. Minimally invasive surgery for primary supratentorial intracerebral haemorrhage. J Clin Neurosci. 2013;20(12):1650–1658.

4

Barnes B, Hanley DF, Carhuapoma JR. Minimally invasive surgery for intracerebral haemorrhage. Curr Opin Crit Care. 2014;20(2):148–152.

5

Sattur MG, Spiotta AM. Commentary: Efficacy and Safety of Minimally Invasive Surgery With Thrombolysis in Intracerebral Haemorrhage Evacuation (MISTIE Ⅲ): A Randomized, Controlled, Open-Label, Blinded Endpoint Phase 3 Trial. Neurosurgery. 2020;86(5):E444. E446.

6

Hanley DF et al.. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016;15(12):1228–1237.

7

Xiao M et al.. Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders. Front Neurosci. 2020;14:764.

8

Chen X et al.. Memantine protects blood-brain barrier integrity and attenuates neurological deficits through inhibiting nitric oxide synthase ser1412 phosphorylation in intracerebral hemorrhage rats: involvement of peroxynitrite-related matrix metalloproteinase-9/NLRP3 inflammasome activation. NeuroReport. 2021;32(3):228–237.

9

Yang Y, Rosenberg GA. MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia. Methods Mol Biol. 2011;762:333–345.

10

Cui JJ et al.. Effects of atorvastatin on pathological changes in brain tissue and plasma MMP-9 in rats with intracerebral hemorrhage. Cell Biochem Biophys. 2012;62(1):87–90.

11

Wu G et al.. Early stage minimally invasive procedures reduce perihematomal MMP-9 and blood-brain barrier disruption in a rabbit model of intracerebral hemorrhage. Neurol Res. 2013;35(6):649–658.

12

Koyama Y, Michinaga S. Regulations of astrocytic functions by endothelins: roles in the pathophysiological responses of damaged brains. J Pharmacol Sci. 2012;118(4):401–407.

13

Hostenbach S et al.. The pathophysiological role of astrocytic endothelin-1. Prog Neurobiol. 2016;144:88–102.

14

Secades JJ et al.. Subarachnoid hemorrhage, cerebral ischemia and endothelin-1. Rev Neurol. 2000;30(1):27–34.

15

Suzuki K et al.. Endothelin-1 concentration increases in the cerebrospinal fluid in cerebral vasospasm caused by subarachnoid hemorrhage. Surg Neurol. 2000;53(2):131–135.

16

Sapira V et al.. Study of endothelin-1 in acute ischemic stroke. Rom J Intern Med. 2010;48(4):329–332.

17

Wang LK et al.. Perihematomal endothelin-1 level is associated with an increase in blood-brain barrier permeability in a rabbit model of intracerebral hematoma. Chin Med J (Engl). 2013;126(18):3433–3438.

18

Rogers SD et al.. Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS. Glia. 2003;41(2):180–190.

19

Murphy JA, Archibald ML, Chauhan BC. The role of endothelin-1 and its receptors in optic nerve head astrocyte proliferation. Br J Ophthalmol. 2010;94(9):1233–1238.

20

Michinaga S et al.. Endothelin receptor antagonists alleviate blood-brain barrier disruption and cerebral edema in a mouse model of traumatic brain injury: A comparison between bosentan and ambrisentan. Neuropharmacology. 2020;175 108182.

21

Gulati A et al.. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke. CNS Drugs. 2021;35(1):85–104.

22

Rusciano I et al.. Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology. Adv Biol Regul. 2021;79 100771.

23

Wang HH, Hsieh HL, Yang CM. Nitric oxide production by endothelin-1 enhances astrocytic migration via the tyrosine nitration of matrix metalloproteinase-9. J Cell Physiol. 2011;226(9):2244–2256.

24

Wang HH et al.. Endothelin-1 enhances cell migration via matrix metalloproteinase-9 up-regulation in brain astrocytes. J Neurochem. 2010;113(5):1133–1149.

25

Menon B, Ramalingam K, Kumar R. Evaluating the Role of Oxidative Stress in Acute Ischemic Stroke. J Neurosci Rural Pract. 2020;11(1):156–159.

26

Wang L et al.. Minimally invasive procedures reduce perihematomal endothelin-1 levels and the permeability of the BBB in a rabbit model of intracerebral hematoma. Neurol Sci. 2013;34(1):41–49.

27

Ironside N et al.. Perihematomal Edema After Spontaneous Intracerebral Hemorrhage. Stroke. 2019;50(6):1626–1633.

28

Michinaga S et al.. Delayed Administration of BQ788, an ETB Antagonist, after Experimental Traumatic Brain Injury Promotes Recovery of Blood-Brain Barrier Function and a Reduction of Cerebral Edema in Mice. J Neurotrauma. 2018;35(13):1481–1494.

29

Michinaga S et al.. Angiopoietin-1/Tie-2 signal after focal traumatic brain injury is potentiated by BQ788, an ETB receptor antagonist, in the mouse cerebrum: Involvement in recovery of blood-brain barrier function. J Neurochem. 2020;154(3):330–348.

30

Michinaga S et al.. Improvement of cold injury-induced mouse brain edema by endothelin ETB antagonists is accompanied by decreases in matrixmetalloproteinase 9 and vascular endothelial growth factor-A. Eur J Neurosci. 2015;42(6):2356–2370.

Brain Hemorrhages
Pages 177-183
Cite this article:
Li C, Meng X, Wang L, et al. Mitigating the effects of Endothelin-1 following a minimally invasive surgery reduces the blood-brain barrier permeability in a rabbit model of intracerebral hemorrhage. Brain Hemorrhages, 2022, 3(4): 177-183. https://doi.org/10.1016/j.hest.2022.06.004

91

Views

0

Downloads

3

Crossref

2

Web of Science

2

Scopus

Altmetrics

Received: 05 April 2022
Revised: 16 June 2022
Accepted: 20 June 2022
Published: 25 June 2022
© 2022 International Hemorrhagic Stroke Association.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return